IASST Guwahati, inks MoU with Bharat Biotech International Ltd. (BBIL), Hyderabad

Current Context: The Institute of Advanced Study in Science and Technology (IASST), Guwahati, signed a Memorandum of Understanding (MoU) with Bharat Biotech International Ltd. (BBIL), Hyderabad, on October 24, 2024, in Guwahati.

• The aim is to develop probiotic health products from traditional fermented foods of Northeast India, addressing metabolic diseases and promoting healthy ageing.
• Key Details:
• Signatories: The MoU was signed by Dr. Ashis K. Mukherjee, Director, IASST, and Dr. Krishna Ella, Chairman and Managing Director, Bharat Biotech.
• Research Focus: The collaboration targets the potential health benefits of probiotics found in the traditional fermented foods of the Northeast region.
• Project Phases: The agreement outlines multiple phases, including extensive pre-clinical and clinical studies to validate the efficacy of the probiotic formulations.
• Commercialization: Bharat Biotech will handle the commercialization aspect, ensuring the products reach the market efficiently.
• Collaborative Benefits: This partnership is expected to leverage IASST's extensive research capabilities and Bharat Biotech's expertise in biotechnology and pharmaceutical production.

Question:

1 What is the primary aim of the MoU between IASST and Bharat Biotech?

• A) Develop probiotic health products from traditional fermented foods
• B) Develop new vaccines
• C) Create new biotechnological equipment
• D) Establish a research facility in Hyderabad

Answer: A) The primary aim is to develop probiotic health products from traditional fermented foods of Northeast India.